The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Adrenocortical cancer: pathophysiology and clinical management
Open accessAbstract
Adrenocortical cancer (ACC) is a rare tumor with a poor prognosis. By contrast, benign adrenocortical tumors are frequent, underlying the importance of a correct diagnosis of malignancy of such tumors. ACC can be diagnosed by the investigation of endocrine signs of steroid excess, symptoms due to tumor growth or an adrenal incidentaloma. Hormonal investigations demonstrate in most ACC steroid oversecretion, the dominant characteristics being a co-secretion of cortisol and androgens. Imaging by CT-scan or MRI shows a large heterogeneous tumor with a low fat content. Careful pathological investigation with the assessment of the Weiss score is important for the diagnosis of malignancy. Molecular markers can also be helpful and in the future might be important for prognosis. Tumors localized to the adrenal gland (McFarlane stages 1 and 2) have a better outcome than invasive and metastatic tumors (stages 3 and 4). Tumor removal by a specialized team is crucial for treatment and should always aim at complete removal. In patients with metastatic or progressive disease, medical treatment is started with mitotane that requires a close monitoring of its blood level. Surgery is indicated when possible for local recurrence but also in some cases of metastasis. Local treatment (radiofrequency, chemoembolization, and radiation therapy) can have some indications for metastatic disease. In patients with disease progression cytotoxic chemotherapy can be used. Despite the best care, the overall prognosis of ACC is poor with a 5-year survival rate below 30% in most series. Therefore, progress in the understanding of the pathophysiology of ACC is important. Despite the rarity of ACC, significant advances have been made in the understanding of its pathogenesis the last decade. These progresses came mainly from the study of the genetics of ACC, both at the germline level in rare familial diseases, and at the somatic level by the study of molecular alterations in sporadic tumors. These advances underline the importance of genetic alterations in ACC development and point-out to various chromosomal regions (2, 11p15, 11q, 17p13) and genes (IGF-II, p53, β-catenin, ACTH receptor). This review will summarize these advances as well as the current clinical management of ACC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Molecular and cellular endocrinology
(1995) · Journal of Endocrinology · doi:10.1677/joe.0.147so19 · Cited by 1,991
Parental imprinting of the mouse insulin-like growth factor II gene
DeChiara, T. M., Robertson, E. J., & Efstratiadis, A. (1991) · Cell · doi:10.1016/0092-8674(91)90513-x · Cited by 1,783
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., GORDON, H., CARPENTER, P. C., SHENOY, B. V., & W. GO, V. L. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,114
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 3×
“By contrast, adrenocortical cancer (ACC) is rare, with an estimated prevalence between 4 and 12 per million in Endocrine-Related Cancer (2007) 14 13–28 1351–0088/07/014–013 q 2007 Society for Endocrinology Printed in Great adults (Grumbach et al. 2003).”
BackgroundInfluentialComparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920 · cited 1×
“Since the initial paper of Weiss (1984), it is assumed that a score above 3 is most likely to be associated with a malignant tumor.”
BackgroundHeterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Lee, M. H., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889
Relaxation of imprinted genes in human cancer
Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., & Feinberg, A. P. (1993) · Nature · doi:10.1038/362747a0 · Cited by 792
Understanding Ras: ‘it ain’t over ’til it’s over’
Shields, J. M., Pruitt, K., McFall, A., Shaub, A., & Der, C. J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01740-2 · Cited by 780
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717
Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour
Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., & Reeve, A. E. (1993) · Nature · doi:10.1038/362749a0 · Cited by 707
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature
Boland, G. W., Lee, M. J., Gazelle, G. S., Halpern, E. F., McNicholas, M. M., & Mueller, P. R. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.1.9648789 · Cited by 693
Tumour-suppressor activity of H19 RNA
Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., & Tycko, B. (1993) · Nature · doi:10.1038/365764a0 · Cited by 630
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Multiple Primary Cancers in Families With Li-Fraumeni Syndrome
Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 557
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541
Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
The American journal of surgical pathology
Wilkins, L. W. (1977) · Cited by 501
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474
Self-citationp53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
Wales, M. M., Biel, M. A., Deiry, W. E., Nelkin, B. D., Issa, J.-P., Cavenee, W. K., Kuerbitz, S. J., & Baylin, S. B. (1995) · Nature Medicine · doi:10.1038/nm0695-570 · Cited by 421
Management of patients with adrenal cancer: recommendations of an international consensus conference
Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01029 · Cited by 421
Kirschner, L. S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3037 · Cited by 402
Peña, C. S., Boland, G. W. L., Hahn, P. F., Lee, M. J., & Mueller, P. R. (2000) · Radiology · doi:10.1148/radiology.217.3.r00dc29798 · Cited by 399
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383
Endocrinology and Metabolism Clinics of North America
Galoiu, S. (2008) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2008.361 · Cited by 336
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
Stojadinovic, A., Ghossein, R. A., Hoos, A., Nissan, A., Marshall, D., Dudas, M. E., Cordon‐Cardo, C., Jaques, D. P., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.941 · Cited by 312
Berruti, A., Terzolo, M., Sperone, P., Pia, A., Della Casa, S., Gross, D. J., Carnaghi, C., Casali, P., Porpiglia, F., Mantero, F., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01025 · Cited by 308
A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer
DiGiammarino, E. L., Lee, A. S., Cadwell, C., Zhang, W., Bothner, B., Ribeiro, R. C., Zambetti, G., & Kriwacki, R. W. (2002) · Nature Structural Biology · doi:10.1038/nsb730 · Cited by 294
Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
Self-citationTumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome
Wiedemann, H. R. (1983) · European Journal of Pediatrics · doi:10.1007/bf00496807 · Cited by 281 · cited 1×
“This overgrowth disorder is characterized by macrosomia, macroglossia, organomegaly, and developmental abnormalities (in particular, abdominal wall defects with exomphalos), embryonal tumors, such as Wilms’ tumor – and ACC (Wiedmann 1983, Hertel et al. 2003), neuroblastoma, and hepatoblastoma.”
BackgroundAngiogenesis in Endocrine Tumors
Turner, H. E., Harris, A. L., Melmed, S., & Wass, J. A. H. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0008 · Cited by 275
Hutter, A. M., & Kayhoe, D. E. (1966) · The American Journal of Medicine · doi:10.1016/0002-9343(66)90220-8 · Cited by 271
Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors
Varley, J. M., McGown, G., Thorncroft, M., James, L. A., Margison, G. P., Forster, G., Evans, D. G. R., Harris, M., Kelsey, A. M., & Birch, J. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302575 · Cited by 266
Hamrahian, A. H., Ioachimescu, A. G., Remer, E. M., Motta-Ramirez, G., Bogabathina, H., Levin, H. S., Reddy, S., Gill, I. S., Siperstein, A., & Bravo, E. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1627 · Cited by 266
Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases
Wood, B. J., Abraham, J., Hvizda, J. L., Alexander, H. R., & Fojo, T. (2003) · Cancer · doi:10.1002/cncr.11084 · Cited by 264
de Fraipont, F., El Atifi, M., Cherradi, N., Le Moigne, G., Defaye, G., Houlgatte, R., Bertherat, J., Bertagna, X., Plouin, P.-F., Baudin, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1075 · Cited by 261
Self-citationTumor formation by genetic mutations in the components of the Wnt signaling pathway
Kikuchi, A. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01424.x · Cited by 260
Sullan, M., Boileau, M., & Hodges, C. V. (1978) · Journal of Urology · doi:10.1016/s0022-5347(17)57317-6 · Cited by 255
Bertherat, J. Y., Groussin, L., Sandrini, F., Matyakhina, L., Bei, T. A., Stergiopoulos, S. G., Papageorgiou, T., Bourdeau, I., Kirschner, L. S., Vincent-Dejean, C., et al. (2003) · PubMed · Cited by 250
Self-citationNatural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients
Didolkar, M. S., Bescher, R. A., Elias, E. G., & Moore, R. H. (1981) · Cancer · doi:10.1002/1097-0142(19810501)47:9<2153::aid-cncr2820470908>3.0.co;2-6 · Cited by 244
Baudin, E., Pellegriti, G., Bonnay, M., Penfornis, A., Laplanche, A., Vassal, G., & Schlumberger, M. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1385::aid-cncr1461>3.0.co;2-2 · Cited by 239
Insulin-Like Growth Factor Receptors
Nissley, P., & Lopaczynski, W. (1991) · Growth Factors · doi:10.3109/08977199109000269 · Cited by 234
p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies
Reincke, M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.3.790 · Cited by 228
High frequency of germline p53 mutations in childhood adrenocortical cancer
Wagner, J., Portwine, C., Rabin, K., Leclerc, J.-M., Narod, S. A., & Malkin, D. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.22.1707 · Cited by 227 · cited 5×
“These assays are adapted from the recommendation of the ACC working group of the European Network for the Study of Adrenal Tumors (ENSAT), the steroids in italics are not part of the minimal ENSAT work-up.”
BackgroundInfluentialLatronico, A. C., Pinto, E. M., Domenice, S., Fragoso, M. C. B. V., Martin, R. M., Zerbini, M. C., Lucon, A. M., & Mendonca, B. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7957 · Cited by 224
Management of adrenocortical carcinoma
Allolio, B., Hahner, S., Weismann, D., & Fassnacht, M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01881.x · Cited by 214
Gicquel, C., Raffin-Sanson, M.-L., Gaston, V., Bertagna, X., Plouin, P.-F., Schlumberger, M., Louvel, A., Luton, J.-P., & Le Bouc, Y. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4170 · Cited by 213
Minireview: PRKAR1A: Normal and Abnormal Functions
Bossis, I., & Stratakis, C. A. (2004) · Endocrinology · doi:10.1210/en.2004-0900 · Cited by 205
van Slooten, H., Moolenaar, A. J., van Seter, A. P., & Smeenk, D. (1984) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(84)90033-6 · Cited by 198
Groussin, L., Kirschner, L. S., Vincent-Dejean, C., Perlemoine, K., Jullian, E., Delemer, B., Zacharieva, S., Pignatelli, D., Carney, J. A., Luton, J. P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344579 · Cited by 192
Self-citationKjellman, M., Kallioniemi, O., Karhu, R., Höög, A., Farnebo, L. ‐., Auer, G., Larsson, C., & Bäckdahl, M. (1996) · PubMed · Cited by 190
Boulle, N., Logié, A., Gicquel, C., Périn, L., & Bouc, Y. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4816 · Cited by 185
Gicquel, C. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.8.2559 · Cited by 184
Khan, T. S., Imam, H., Juhlin, C., Skogseid, B., Gröndal, S., Tibblin, S., Wilander, E., Öberg, K., & Eriksson, B. (2000) · Annals of Oncology · doi:10.1023/a:1008377915129 · Cited by 183
Lam, W. W. K., Hatada, I., Ohishi, S., Mukai, T., Joyce, J. A., Cole, T. R. P., Donnai, D., Reik, W., Schofield, P. N., & Maher, E. R. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.7.518 · Cited by 179
Leboulleux, S., Dromain, C., Bonniaud, G., Aupérin, A., Caillou, B., Lumbroso, J., Sigal, R., Baudin, E., & Schlumberger, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1540 · Cited by 170
Groussin, L., Jullian, E., Perlemoine, K., Louvel, A., Leheup, B., Luton, J. P., Bertagna, X., & Bertherat, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020592 · Cited by 169
Self-citationMultiple Endocrine Neoplasia--Syndromes of the Twentieth Century
Thakker, R. V. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2617 · Cited by 169
Molecular genetics of adrenocortical tumours, from familial to sporadic diseases
Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168
Self-citationDohna, M., Reincke, M., Mincheva, A., Allolio, B., Solinas-Toldo, S., & Lichter, P. (2000) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200006)28:2<145::aid-gcc3>3.0.co;2-7 · Cited by 163
Veugelers, M., Wilkes, D. C., Burton, K. A., McDermott, D. A., Song, Y., Goldstein, M. M., Perle, K. L., Vaughan, C. J., O'Hagan, A. H., Bennett, K. R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405535101 · Cited by 163
Ilvesmäki, V., Kahri, A. I., Miettinen, P. J., & Voutilainen, R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.3.8370710 · Cited by 152
Guignat, L., BERTAGNA, X. Y., & Bertherat, J. Y. (2008) · PubMed · Cited by 149
Self-citationComparative Genomic Hybridization Analysis of Adrenocortical Tumors
Sidhu, S. B., Marsh, D. J., Theodosopoulos, G., Philips, J. N., Bambach, C. P., Campbell, P. R., Magarey, C. J., Russell, C. F. J., Schulte, K., Röher, H. D., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8697 · Cited by 145
Hennings, J., Lindhe, Ö., Bergström, M., Långström, B., Sundin, A., & Hellman, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2273 · Cited by 141
p53 Mutations in sporadic adrenocortical tumors
Ohgaki, H., Kleihues, P., & Heitz, P. U. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540310 · Cited by 139
Mesiano, S., Mellon, S. H., & Jaffe, R. B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.4.8473412 · Cited by 135
APRKAR1AMutation Associated with Primary Pigmented Nodular Adrenocortical Disease in 12 Kindreds
Groussin, L., Horvath, A., Jullian, E. H., Boikos, S. A., René-Corail, F., Lefèbvre, H., Cephise-Velayoudom, F.-L., Vantyghem, M., Chanson, P., Conte‐Devolx, B., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2708 · Cited by 134
Self-citationBourdeau, I., Antonini, S. R. R., Lacroix, A., Kirschner, L. S., Matyakhina, L., Lorang, D., Libutti, S. K., & Stratakis, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207277 · Cited by 133
Clonal composition of human adrenocortical neoplasms.
Beuschlein, F., Reincke, M., Karl, M., Travis, W. D., Jaursch-Hancke, C., Abdelhamid, S., Chrousos, G. P., & Allolio, B. (1994) · PubMed · Cited by 129
Genetic Changes in Human Adrenocortical Carcinomas
Yano, T., Linehan, W. M., Angland, P., Lerman, M. I., Daniel, L. N., Stein, C. A., Roberston, C., Larocca, R. V., & Zbar, B. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.518 · Cited by 129
Boulle, N. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1713 · Cited by 127
Scintigraphic evaluation of clinically silent adrenal masses.
Gross, M. D., Shapiro, B., Francis, I. R., Glazer, G. M., Bree, R. L., Arcomano, M. A., SCHTEINGART, D. E., McLeod, M. K., Sanfield, J. A., & Thompson, N. W. (1994) · PubMed · Cited by 121
Mutations of the p53 gene in human functional adrenal neoplasms
Lin, S. R., Lee, Y. J., & Tsai, J. H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106638 · Cited by 121
Laparoscopic adrenalectomy for malignancy
Cobb, W. S., Kercher, K. W., Sing, R. F., & Heniford, B. T. (2005) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2005.01.021 · Cited by 119
Kjellman, M., Roshani, L., Teh, B. T., Kallioniemi, O., Höög, A., Gray, S. G., Farnebo, L., Holst, M., Bäckdahl, M., & Larsson, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5506 · Cited by 115
Clonal analysis of human adrenocortical carcinomas and secreting adenomas
Gicquel, C., Leblond‐Francillard, M., Bertagna, X., Louvel, A., Chapuls, Y., Luton, J., Girard, F., & Le Bouc, Y. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02485.x · Cited by 111
Reincke, M., Mora, P., Beuschlein, F., Arlt, W., Chrousos, G. P., & Allolio, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4211 · Cited by 109
MEN1 Gene Analysis in Sporadic Adrenocortical Neoplasms
Heppner, C., Reincke, M., Agarwal, S. K., Mora, P., Allolio, B., Burns, A. L., Spiegel, A. M., & Marx, S. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5388 · Cited by 108
Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope
Kirschner, L. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1739 · Cited by 107
Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line
Logié, A., Boulle, N., Gaston, V., Périn, L., Boudou, P., Bouc, Y. L., & Gicquel, C. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0230023 · Cited by 105
Analysis of Genomic Alterations in Sporadic Adrenocortical Lesions
Zhao, J., Speel, E. M., Muletta-Feurer, S., Rütimann, K., Saremaslani, P., Roth, J., Heitz, P. U., & Komminoth, P. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65205-4 · Cited by 104
FDG-PET in Adrenocortical Carcinoma
Becherer, A., Vierhapper, H., Pötzi, C., Karanikas, G., Kurtaran, A., Schmaljohann, J., Staudenherz, A., Dudczak, R., & Kletter, K. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801753131363 · Cited by 104
Adrenal cortical carcinoma in Norway, 1970–1984
Søreide, J. A., Brabrand, K., & Thoresen, S. (1992) · World Journal of Surgery · doi:10.1007/bf02067349 · Cited by 104
Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors
Terzolo, M., Boccuzzi, A., Bovio, S., Cappia, S., Giuli, P. D., Alì, A., Paccotti, P., Porpiglia, F., Fontana, D., & Angeli, A. (2001) · Urology · doi:10.1016/s0090-4295(00)00852-9 · Cited by 103
Hotta, M., & Baird, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7795 · Cited by 103
Gao, Z.-H., Suppola, S., Liu, J., Heikkilä, P., Jänne, J., & Voutilainen, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8331 · Cited by 102
Maurea, S., Klain, M., Mainolfi, C. G., Ziviello, M., & Salvatore, M. (2001) · PubMed · Cited by 101
Characterization of Adrenal Masses Using Unenhanced CT: An Analysis of the CT Literature
Boland, G. W., Lee, M. J., Gazelle, G. S., Halpern, E. F., McNicholas, M. M. J., & Müeller, P. R. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)62163-3 · Cited by 99
Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands
Weber, M. M., Auernhammer, C. J., Kieß, W., & Engelhardt, D. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360296 · Cited by 95
Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors
Barzon, L., Chilosi, M., Fallo, F., Martignoni, G., Montagna, L., Palu, G., & Boscaro, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450207 · Cited by 94
Mesiano, S., Mellon, S. H., Gospodarowicz, D., Di Blasio, A. M., & Jaffe, R. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5428 · Cited by 85
de Fraipont, F., Atifi, M. E., Gicquel, C., BERTAGNA, X. Y., CHAMBAZ, E. M., & Feige, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7012 · Cited by 85
MEN1 Gene Analysis in Sporadic Adrenocortical Neoplasms
Heppner, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.216 · Cited by 76
Interleukin-3 and interleukin-6 stimulate cortisol secretion from adult human adrenocortical cells
Weber, M. M., Michl, P., Auernhammer, C. J., & Engelhardt, D. (1997) · Endocrinology · doi:10.1210/endo.138.5.5239 · Cited by 74
Reincke, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.9.3054 · Cited by 74
Luton, J., Martinez, M., Coste, J., & Bertherat, J. Y. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430111 · Cited by 71
Self-citationAngiogenesis in Human Normal and Pathologic Adrenal Cortex
BERNINI, G. P., Moretti, A., Bonadio, A. G., Menicagli, M., Viacava, P., Naccarato, A. G., Iacconi, P., Miccoli, P., & Salvetti, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011799 · Cited by 69
Liu, J., Kahri, A. I., Heikkilä, P., & Voutilainen, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3968 · Cited by 66
Recent advances in the pathogenesis of adrenocortical tumours
Gicquel, C., BERTAGNA, X. Y., & Bouc, Y. L. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330133 · Cited by 65
Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
Kołomecki, K., Stepien, H., Bartos, M., & Kuzdak, K. (2001) · PubMed · Cited by 65
Kjellman, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.730 · Cited by 64
Adrenal adenomas in a patient with Gardner's syndrome
Naylor, E. W., & Gardner, E. I. (1981) · Clinical Genetics · doi:10.1111/j.1399-0004.1981.tb01810.x · Cited by 63
Cushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients.
Guilhaume, B., Raffin‐Sanson, M., BILLAUD, L., BERTAGNA, X. Y., Laudat, M. H., & LUTON, J. P. (1992) · PubMed · Cited by 60
Bläker, H., Sutter, C., Kadmon, M., Otto, H. F., Doeberitz, M. V. K., Gebert, J. F., & Helmke, B. M. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20071 · Cited by 60
Fine tuning of adrenocortical functions by locally produced growth factors
Feige, J., Vilgrain, I., Brand, C., Bailly, S., & Souchelnitskiy, S. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1580007 · Cited by 59
Tenenbaum, F., Groussin, L., Foehrenbach, H., Tissier, F., Gouya, H., Bertherat, J. Y., Dousset, B. E., Legmann, P., Richard, B., & BERTAGNA, X. Y. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500789 · Cited by 59
Self-citationSchulte, K., Mengel, M., Heinze, M., Simon, D., Scheuring, S., Köhrer, K., & Röher, H. D. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6312 · Cited by 58
Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors
Tissier, F., Louvel, A., Grabar, S., Hagnéré, A.-M., Bertherat, J. Y., Vacher‐Lavenu, M., Dousset, B. E., Chapuis, Y., BERTAGNA, X. Y., & Gicquel, C. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500809 · Cited by 57
Self-citationGicquel, C., Bertherat, J. Y., Bouc, Y. L., & BERTAGNA, X. Y. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70112-2 · Cited by 54
Self-citationde Fraipont, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4734 · Cited by 52
Reincke, M., Beuschlein, F., Menig, G., Hofmockel, G., Arlt, W., LEHMANN, R., Karl, M., & Allolio, B. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560415 · Cited by 51
Mutations of K-ras oncogene in human adrenal tumours in Taiwan
Lin, S.-R., Tsai, J. H., Yang, Y., & Lee, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.177 · Cited by 50
Reincke, M., Wachenfeld, C., Mora, P., THUMSER, A. E. A., Jaursch-Hancke, C., Abdelhamid, S., Chrousos, G. P., & Allolio, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855814 · Cited by 46
Absent Ras Gene Mutations in Human Adrenal Cortical Neoplasms and Pheochromocytomas
Moul, J. W., Bishoff, J. T., Theune, S. M., & Chang, E. H. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)36397-8 · Cited by 43
Transforming Growth Factor ß1: An Autocrine Regulator of Adrenocortical Steroidogenesis
Feige, J., Cochet, C., Savona‐Baron, C., Shi, D., Kéramidas, M., Defaye, G., & CHAMBAZ, E. M. (1991) · Endocrine Research · doi:10.1080/07435809109027201 · Cited by 40
Boulle, N., Gicquel, C., Logié, A., Christol, R., Feige, J., & Bouc, Y. L. (2000) · Endocrinology · doi:10.1210/endo.141.9.7632 · Cited by 39
Pohlink, C., Tannapfel, A., Eichfeld, U., Schmidt, F., Führer, D., Paschke, R., & Koch, C. A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347480 · Cited by 38
Faßnacht, M., Beuschlein, F., Vay, S., Mora, P., Allolio, B., & Reincke, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590035 · Cited by 35
Liu, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1766 · Cited by 33
Favia, G., Lumachi, F., & D'Amico, D. F. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0024-5 · Cited by 32
Hertel, N. T., Carlsen, N., Kerndrup, G. B., PEDERSEN, I. L., Clausen, N., Hahnemann, J., & Jacobsen, B. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00575.x · Cited by 31
Ilvesmäki, V., Jäättelä, M., SAKSELA, E., & Voutilainen, R. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90255-i · Cited by 23
Connors, M. H. (1978) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1978.02120340112027 · Cited by 23
PCR-SSCP analysis of human adrenocortical adenomas: absence of K-ras gene mutations
Ocker, M., Sachse, R., Rico, A. F., & Hensen, J. (2000) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2000-11006 · Cited by 11
Protein kinase A in Carney complex: a new example of cAMP pathway alteration in endocrine tumors
Bertherat, J. Y. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440209 · Cited by 11
Self-citationTransforming Growth Factor β1: Implications in Adrenocortical Tumorigenesis
Arnaldi, G., Freddi, S., Mancini, T., Kola, B., & Mantero, F. (2000) · Endocrine Research · doi:10.3109/07435800009048615 · Cited by 6
Venkatesh (1989) · doi:10.1002/1097-0142(19890801)64:3
Wooten (1993) · doi:10.1002/1097-0142(19931201)72:11<3145::aid-cncr2820721105>3.0.co;2-n
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Kasperlik-Załuska (1995) · doi:10.1002/1097-0142(19950515)75:10<2587::aid-cncr2820751028>3.0.co;2-5
Cited by
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 961
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Fassnacht, M., Terzolo, M., Allolio, B., Baudin, E., Haak, H., Berruti, A., Welin, S., Schade-Brittinger, C., Lacroix, A., Jarzab, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200966 · Cited by 873
Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Pelsma, I., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 786
Integrated genomic characterization of adrenocortical carcinoma
Assié, G., Letouzé, E., Fassnacht, M., Jouinot, A., Luscap, W., Barreau, O., Omeiri, H., Rodriguez, S., Perlemoine, K., René-Corail, F., et al. (2014) · Nature Genetics · doi:10.1038/ng.2953 · Cited by 732
Self-citation
Metadata
- Authors
- Libè, R., Fratticci, A., & Bertherat, J.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2007-03
- Volume
- 14
- Issue
- 1
- Pages
- 13-28
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2105635119
- Cited by
- 272
- References
- 137
- FWCI
- 25.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.